Spectral AI Inc is an AI company focused on predictive medical diagnostics. Its DeepView System uses proprietary AI algorithms to distinguish between fully damaged, partially damaged and healthy human tissue characters invisible to the naked eye, at the initial time point of wound presentation. The DeepView System delivers a binary prediction on the wound's capacity to heal or not-heal by a specified time point in the future. The company focuses on the burn indication which is supported by the BARDA PBS contract.
Last trade$1.34
Day change+$0.025 (+1.91%)
Day range$1.26 – $1.38
Volume85,247
Market cap$42M
OpenXNAS
Fundamentals
Key company ratios and reported financial statements.
Source: Massive.com
Key ratios
Valuation
Market capitalization
$42.16M
Price / earnings
—
Price / book
-3.5×
Price / sales
2.74×
EV / sales
2.8×
EV / EBITDA
-3.66×
Profitability
Earnings per share
-$0.31
Return on assets
-51.9%
Return on equity
83.69%
Dividend yield
0%
Liquidity and leverage
Debt / equity
-1.24×
Current ratio
0.9×
Quick ratio
0.85×
Cash ratio
0.7×
Cash flow
Price / cash flow
—
Price / free cash flow
—
Free cash flow
-$12.88M
Ratios use trailing-twelve-month financials and market data as of
Nov 16, 2026.
Financial statements
Income and cash flow amounts are for the period; balance sheets are point-in-time
snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are
displayed when available.
Income statement for MDAI, quarterly periods
Line item
Q2 FY2026 Jun 30, 2026
Q1 FY2026 Mar 31, 2026
Q4 FY2025 Dec 31, 2025
Q3 FY2025 Sep 30, 2025
Q2 FY2025 Jun 30, 2025
Q1 FY2025 Mar 31, 2025
Q4 FY2024 Dec 31, 2024
Q3 FY2024 Sep 30, 2024
Revenue
$3.52M
$3.99M
$4.09M
$3.79M
$5.07M
$6.71M
$7.6M
$8.17M
Cost of revenue
$2.41M
$1.96M
$2.24M
$2.17M
$2.78M
$3.54M
$4.26M
$4.51M
Gross profit
$1.11M
$2.03M
$1.85M
$1.62M
$2.29M
$3.17M
$3.35M
$3.67M
Selling, general and administrative
$3.74M
$4M
$4.09M
$4.96M
$2.96M
$4.06M
$4.46M
$4.55M
Research and development
$1.7M
$0
$0
$0
$1.46M
$0
$0
$0
Total operating expenses
$5.44M
$4M
$4.09M
$4.96M
$4.41M
$4.06M
$4.46M
$4.55M
Operating income
-$4.32M
-$1.97M
-$2.24M
-$3.34M
-$2.12M
-$896K
-$1.11M
-$886K
Interest expense
-$383K
-$265K
-$1.34M
-$300K
-$401K
-$601K
-$2.95M
-$8K
Income before taxes
-$4.01M
-$3.42M
$1.01M
-$3.55M
-$7.99M
$2.97M
-$7.6M
-$1.47M
Income taxes
$170K
-$10K
-$43K
$2K
-$19K
$71K
-$14K
$37K
Net income
-$4.18M
-$3.41M
$1.05M
-$3.55M
-$7.97M
$2.9M
-$7.59M
-$1.5M
Net income attributable to common shareholders
-$4.18M
-$3.41M
$1.05M
-$3.55M
-$7.97M
$2.9M
-$7.59M
-$1.5M
EBITDA
-$4.29M
-$1.94M
-$2.21M
-$3.31M
-$2.11M
-$894K
-$1.11M
-$885K
Basic earnings per share
-$0.13
-$0.11
$0.03
-$0.13
-$0.31
$0.13
-$0.38
-$0.08
Diluted earnings per share
-$0.13
-$0.11
$0.03
-$0.13
-$0.31
$0.11
-$0.38
-$0.08
Recent news
Company coverage with links to the original publishers.
Spectral AI showcased its DeepView System at the Southern Region Burn Conference, demonstrating its AI technology for objective burn wound assessment. The company aims to improve patient outcomes and reduce healthcare costs through innovative medical diagnostics.
Spectral AI reported a net loss of $3.6 million in Q3 2025, reduced revenue guidance to $18.5 million, and anticipates a flat to slightly lower revenue year in 2026. The company continues to progress towards FDA clearance for its DeepView medical device and is expanding international market presence.
Spectral AI reported Q3 2025 financial results with $3.8 million in research and development revenue, a net loss of $3.6 million, and a strong cash position of $10.5 million. The company continues to progress towards FDA De Novo submission for its DeepView® System in wound care diagnostics.
Spectral AI will report its third quarter 2025 financial results on November 11, 2025, after market close, with a conference call to discuss the results.
Spectral AI, a medical diagnostics AI company, was recognized on TIME's World's Top HealthTech Companies 2025 list for its innovative DeepView technology focused on wound care and burn treatment diagnostics.
Dividends
Declared distributions and recorded event dates. Forecasts are not
shown.
Updated daily
No declared upcoming dividend found.
No prior dividend records found.
Stock splits
Historical share-structure events and their execution dates.